Compare Johnson Controls International PLC (JCI) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson Controls International PLC vs Regeneron Pharmaceuticals Inc — how do they compare? Johnson Controls International PLC trades at $155.29 (market cap $93.74B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Johnson Controls International PLC and Regeneron Pharmaceuticals Inc are close in size by market cap, and Johnson Controls International PLC pays the higher dividend (1.03%). Which is the better fit depends on your goals.
| JCI | REGN | |
|---|---|---|
Market Cap | $93.74B | $82.06B |
Sector | Industrials | Health |
52-Week High | $154.76 | $812.27 |
52-Week Low | $103.52 | $555.51 |
Enterprise Value | $102.58B | $76.77B |
Dividend Yield | 1.03% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Johnson Controls International PLC
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
